Showing results (401-410 of 481) with videos related to

Sort By:
Pageof 49
Journal of Neuro-Aids|January 1, 1996
Neurologic Manifestationsof HIV Infection Without AIDS:Follow-UP of a Cohortof Homosexual and Bisexual MenC M Marra, W T Longstreth, H H Handsfield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298Timothy J Wilkin, Huichao Chen, Michelle S Cespedes, et al.
The Journal of Infectious Diseases|October 31, 2024
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIVNicole H Tobin, Sarah L Brooker, Fan Li, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
Eclinicalmedicine|January 21, 2020
Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in KenyaIngrid A Beck, Molly Levine, Christine J McGrath, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3)Robert S Wallis, Robert Kalayjian, Jeffrey M Jacobson, et al.
The Lancet. HIV|December 11, 2019
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trialMichael H Chung, Christine J McGrath, Ingrid A Beck, et al.
AIDS (London, England)|October 29, 1998
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 StudyR S Sperling, D E Shapiro, G D McSherry, et al.
The Journal of Infectious Diseases|January 4, 2008
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjectsHomer L Twigg Iii, Michael Weiden, Fred Valentine, et al.
Pageof 49